U.S. Food and Drug Administration - CDRH Mobile
Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website
FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule

Class I Medical Device Recall - LifeLine® Semi-Automatic External Defibrillators (AEDs) and ReviveR® Semi-Automatic External Defibrillators (AEDs)

Date Recall Initiated:

February 17, 2007

Product:

Lifeline® Semi-Automatic External Defibrillators (AEDs) and ReviveR® Semi-Automatic External Defibrillators (AEDs)

Use:

Automatic external defibrillators are intended to be used for the treatment of cardiac arrest. The defibrillators deliver a shock to the heart to restore normal heart rhythm. Prior to delivering the shock, the device analyzes the patient’s heart rhythm to determine if a shock is appropriate.

Recalling Firm:

Defibtech®, LLC
741 Boston Post Road, Suite 201
Guilford, CT 06437

Reason for Recall:

Defibtech®, LLC, is initiating a voluntary worldwide recall of Lifeline® Semi-automatic External Defibrillators (AEDs) and ReviveR® Semi-automatic External Defibrillators (AEDs). This recall affects all Lifeline® and ReviveR® AEDs with software versions 2.002 and earlier. The self-test software for these devices may allow a self-test to clear a previously detected low battery condition. If this situation occurs, the operator may be unaware of the low battery, and the device may be unable to deliver a defibrillation shock, which could result in failure to resuscitate a patient.

Public Contact:

Consumers with questions may contact the Customer Service Manager at 1-203-436-6654

FDA District:

New England

FDA Comments:

Defibtech®, LLC, initiated notification of its distributors and customers by letter on February 22, 2007. Defibtech®, LLC, determined the need for this recall after learning of three reports of malfunctions from end users. The company has provided a maintenance procedure that can be used to verify functionality of the device until the software upgrade has been installed, allowing the device to remain in service. A copy of this maintenance procedure is being mailed to customers. This procedure, as well as instructions on determining the software version of a unit, can be found on the www.defibtech.com/fa2007 web page. For questions regarding this recall, please refer to the above referenced web page, contact your distributor or contact Defibtech®, LLC, at techsupport@defibtech.com, 1-877-453-4507 or 1-203-453-4507.

Defibtech®, LLC, will provide customers with a free software upgrade to address this issue for all affected AEDs. This software upgrade will be able to be installed in the field where the unit is located. The software upgrade is expected to be available within the next ten weeks.

Defibtech®, LLC, has distributed approximately 42,000 units worldwide through distributors to end users including: schools, Fire & EMS, businesses, health clubs and hospitality companies. The products can be identified by the words “Lifeline AED®” and “ReviveR AED TM” on the front of the device.

Class I recalls are the most serious type of recall and involve situations in which there is a reasonable probability that, should this particular malfunction occur, use of the affected product may cause serious injury or death if the problem is not corrected.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by FAX.

For more information about this recall, please see the company’s press release at http://www.defibtech.com/news/2007_0307_recall.html.

Updated March 7, 2007

horizonal rule

CDRH Home Page | CDRH A-Z Index | Contact CDRH | Accessibility | Disclaimer
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

Center for Devices and Radiological Health / CDRH